Tuberous xanthomatosis is not necessarily associated with increased plasma concentrations of cholestanol in cerebrotendinous xanthomatosis

Affiliations

• ¹ UMR 1302, Desbrest Institute of Epidemiology and Public Health, University of Montpellier, INSERM, CHU, Montpellier, France.
• ² Endocrinology-Diabetes-Nutrition Department, CHU Montpellier, University of Montpellier, Montpellier, France.
• ³ APHP, Sorbonne University, Pitié-Salpêtrière Hospital, Endocrine and Oncologic Biochemistry, Paris, France.
• ⁴ National Institute for Health and Medical Research (INSERM) UMR_S 1166, Faculty of Medicine Pitie-Salpêtriere, Paris, France.
• ⁵ Sorbonne University, Paris, France.
• ⁶ Dyslipidemia, Nutritional and Digestive Dysfunctions Unit, Department of Biochemistry and Molecular Biology, Biology and Pathology Center - East, Hospices Civils de Lyon, Bron, France.
• ⁷ CarMeN Laboratory, UMR INSERM U1060/INRA U1397, Claude Bernard Lyon 1 University, Bron, France.
• ⁸ Department of Plastic, Reconstructive and Aesthetic Surgery, Burns and Wound Healing Unit, CHRU Lapeyronie, Montpellier, France.
• ⁹ PhyMedExp, University of Montpellier, INSERM U1046, CNRS UMR 9214, M, ontpellier, France.
• ¹⁰ Department of Biochemistry, Hôpital Lapeyronie, CHU Montpellier, Montpellier, France.
• ¹¹ Inborn Errors of Metabolism Unit, Department of Biochemistry and Molecular Biology, Biology and Pathology Center - East, Hospices Civils de Lyon, Bron, France.
• ¹² Department of Endocrinology, Nutrition and Metabolic Diseases, Hospices Civils de Lyon, Louis Pradel Cardiovascular Hospital, Bron, France.